1. Home
  2. ALDX vs MRAM Comparison

ALDX vs MRAM Comparison

Compare ALDX & MRAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • MRAM
  • Stock Information
  • Founded
  • ALDX 2004
  • MRAM 2008
  • Country
  • ALDX United States
  • MRAM United States
  • Employees
  • ALDX N/A
  • MRAM N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • MRAM Semiconductors
  • Sector
  • ALDX Health Care
  • MRAM Technology
  • Exchange
  • ALDX Nasdaq
  • MRAM Nasdaq
  • Market Cap
  • ALDX 133.7M
  • MRAM 114.4M
  • IPO Year
  • ALDX 2014
  • MRAM 2016
  • Fundamental
  • Price
  • ALDX $2.24
  • MRAM $5.92
  • Analyst Decision
  • ALDX Strong Buy
  • MRAM Strong Buy
  • Analyst Count
  • ALDX 2
  • MRAM 2
  • Target Price
  • ALDX $9.50
  • MRAM $9.00
  • AVG Volume (30 Days)
  • ALDX 1.5M
  • MRAM 74.6K
  • Earning Date
  • ALDX 05-20-2025
  • MRAM 04-30-2025
  • Dividend Yield
  • ALDX N/A
  • MRAM N/A
  • EPS Growth
  • ALDX N/A
  • MRAM N/A
  • EPS
  • ALDX N/A
  • MRAM N/A
  • Revenue
  • ALDX N/A
  • MRAM $49,110,000.00
  • Revenue This Year
  • ALDX N/A
  • MRAM $8.07
  • Revenue Next Year
  • ALDX N/A
  • MRAM $17.98
  • P/E Ratio
  • ALDX N/A
  • MRAM N/A
  • Revenue Growth
  • ALDX N/A
  • MRAM N/A
  • 52 Week Low
  • ALDX $1.14
  • MRAM $4.34
  • 52 Week High
  • ALDX $7.20
  • MRAM $7.00
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 36.53
  • MRAM 65.80
  • Support Level
  • ALDX $1.90
  • MRAM $5.57
  • Resistance Level
  • ALDX $2.89
  • MRAM $5.95
  • Average True Range (ATR)
  • ALDX 0.22
  • MRAM 0.25
  • MACD
  • ALDX 0.09
  • MRAM 0.07
  • Stochastic Oscillator
  • ALDX 33.46
  • MRAM 75.23

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

Share on Social Networks: